» Articles » PMID: 34072832

Epigenetic Regulation of Peroxisome Proliferator-Activated Receptor Gamma Mediates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease

Overview
Journal Cells
Publisher MDPI
Date 2021 Jun 2
PMID 34072832
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in Western countries and has become a serious public health concern. Although Western-style dietary patterns, characterized by a high intake of saturated fat, is considered a risk factor for NAFLD, the molecular mechanisms leading to hepatic fat accumulation are still unclear. In this study, we assessed epigenetic regulation of peroxisome proliferator-activated receptor γ (PPARγ), modifications of gene expression, and lipid uptake in the liver of mice fed a high-fat diet (HFD), and in hepatocyte culture challenged with palmitic acid. Bisulfate pyrosequencing revealed that HFD reduced the level of cytosine methylation in the DNA promoter. This was associated with increased expression of the hepatic PPARγ, very low-density lipoprotein receptor (VLDLR) and cluster differentiating 36 (CD36), and enhanced uptake of fatty acids and very low-density lipoprotein, leading to excess hepatic lipid accumulation. Furthermore, palmitic acid overload engendered comparable modifications in hepatocytes, suggesting that dietary fatty acids contribute to the pathogenesis of NAFLD through epigenetic upregulation of PPARγ and its target genes. The significance of epigenetic regulation was further demonstrated in hepatocytes treated with DNA methylation inhibitor, showing marked upregulation of PPARγ and its target genes, leading to enhanced fatty acid uptake and storage. This study demonstrated that HFD-induction of DNA promoter demethylation increased the expression of PPARγ and its target genes, and , leading to excess lipid accumulation, an important initiating mechanism by which HFD increased PPARγ and lipid accumulation. These findings provide strong evidence that modification of the promoter methylation is a crucial mechanism of regulation in NAFLD pathogenesis.

Citing Articles

Oyster Mushroom () Ethanolic Extract Inhibits Pparg Expression While Maintaining the Methylation of the Promoter During 3T3-L1 Adipocyte Differentiation.

Ariyanto E, Farahana A, Sudirman G, Widiarsih E, Qomarilla N, Rahayu N J Exp Pharmacol. 2025; 17():27-36.

PMID: 39834594 PMC: 11745172. DOI: 10.2147/JEP.S494116.


Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Hamamah S, Iatcu O, Covasa M Nutrients. 2025; 17(1.

PMID: 39796579 PMC: 11722922. DOI: 10.3390/nu17010143.


Divergent roles of RIPK3 and MLKL in high-fat diet-induced obesity and MAFLD in mice.

Tye H, Conos S, Djajawi T, Gottschalk T, Abdoulkader N, Kong I Life Sci Alliance. 2024; 8(1).

PMID: 39532538 PMC: 11557689. DOI: 10.26508/lsa.202302446.


Mechanism of Metabolic Dysfunction-associated Steatotic Liver Disease: Important role of lipid metabolism.

Feng X, Zhang R, Yang Z, Zhang K, Xing J J Clin Transl Hepatol. 2024; 12(9):815-826.

PMID: 39280069 PMC: 11393839. DOI: 10.14218/JCTH.2024.00019.


Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead.

Liu R, Li Y, Zheng Q, Ding M, Zhou H, Li X Acta Pharm Sin B. 2024; 14(3):1009-1029.

PMID: 38486982 PMC: 10935124. DOI: 10.1016/j.apsb.2023.10.023.


References
1.
Skat-Rordam J, Ipsen D, Lykkesfeldt J, Tveden-Nyborg P . A role of peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease. Basic Clin Pharmacol Toxicol. 2018; 124(5):528-537. PMC: 6850367. DOI: 10.1111/bcpt.13190. View

2.
Younossi Z, Koenig A, Abdelatif D, Fazel Y, Henry L, Wymer M . Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2015; 64(1):73-84. DOI: 10.1002/hep.28431. View

3.
Hajri T, Tao H, Wattacheril J, Marks-Shulman P, Abumrad N . Regulation of adiponectin production by insulin: interactions with tumor necrosis factor-α and interleukin-6. Am J Physiol Endocrinol Metab. 2010; 300(2):E350-60. PMC: 3280698. DOI: 10.1152/ajpendo.00307.2010. View

4.
Cao Q, Wang X, Jia L, Mondal A, Diallo A, Hawkins G . Inhibiting DNA Methylation by 5-Aza-2'-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation. Endocrinology. 2014; 155(12):4925-38. PMC: 4239421. DOI: 10.1210/en.2014-1595. View

5.
Gavrilova O, Haluzik M, Matsusue K, Cutson J, Johnson L, Dietz K . Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem. 2003; 278(36):34268-76. DOI: 10.1074/jbc.M300043200. View